nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—SLC46A1—Defective AMN causes hereditary megaloblastic anemia 1—SLC25A16—intracranial aneurysm	0.0668	0.0796	CbGpPWpGaD
Sulfasalazine—TBXAS1—Prostaglandin Synthesis and Regulation—EDNRA—intracranial aneurysm	0.0564	0.0672	CbGpPWpGaD
Sulfasalazine—CHUK—RIP-mediated NFkB activation via ZBP1—AGER—intracranial aneurysm	0.0155	0.0184	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.0149	0.0177	CbGpPWpGaD
Sulfasalazine—PPARG—artery—intracranial aneurysm	0.0141	0.0875	CbGeAlD
Sulfasalazine—IKBKB—RIP-mediated NFkB activation via ZBP1—AGER—intracranial aneurysm	0.014	0.0167	CbGpPWpGaD
Sulfasalazine—CHUK—TRAF6 mediated NF-kB activation—AGER—intracranial aneurysm	0.0139	0.0166	CbGpPWpGaD
Sulfasalazine—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC25A16—intracranial aneurysm	0.0136	0.0162	CbGpPWpGaD
Sulfasalazine—CHUK—RANKL/RANK Signaling Pathway—CTSK—intracranial aneurysm	0.0134	0.016	CbGpPWpGaD
Sulfasalazine—ACAT1—medulla oblongata—intracranial aneurysm	0.0133	0.0824	CbGeAlD
Sulfasalazine—CHUK—ZBP1(DAI) mediated induction of type I IFNs—AGER—intracranial aneurysm	0.013	0.0155	CbGpPWpGaD
Sulfasalazine—CHUK—TAK1 activates NFkB by phosphorylation and activation of IKKs complex—AGER—intracranial aneurysm	0.013	0.0155	CbGpPWpGaD
Sulfasalazine—SLC46A1—Folate Metabolism—CCL2—intracranial aneurysm	0.0129	0.0154	CbGpPWpGaD
Sulfasalazine—PTGS1—Prostaglandin Synthesis and Regulation—EDNRA—intracranial aneurysm	0.0126	0.0151	CbGpPWpGaD
Sulfasalazine—IKBKB—TRAF6 mediated NF-kB activation—AGER—intracranial aneurysm	0.0126	0.015	CbGpPWpGaD
Sulfasalazine—IKBKB—RANKL/RANK Signaling Pathway—CTSK—intracranial aneurysm	0.0122	0.0145	CbGpPWpGaD
Sulfasalazine—ACAT1—midbrain—intracranial aneurysm	0.0121	0.0753	CbGeAlD
Sulfasalazine—IKBKB—ZBP1(DAI) mediated induction of type I IFNs—AGER—intracranial aneurysm	0.0118	0.0141	CbGpPWpGaD
Sulfasalazine—IKBKB—TAK1 activates NFkB by phosphorylation and activation of IKKs complex—AGER—intracranial aneurysm	0.0118	0.0141	CbGpPWpGaD
Sulfasalazine—CHUK—Osteopontin Signaling—MMP9—intracranial aneurysm	0.0117	0.0139	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.0113	0.0134	CbGpPWpGaD
Sulfasalazine—IKBKB—Osteopontin Signaling—MMP9—intracranial aneurysm	0.0106	0.0126	CbGpPWpGaD
Sulfasalazine—PTGS2—Prostaglandin Synthesis and Regulation—EDNRA—intracranial aneurysm	0.01	0.012	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism—SLC25A16—intracranial aneurysm	0.01	0.0119	CbGpPWpGaD
Sulfasalazine—CHUK—AGE/RAGE pathway—NCF1—intracranial aneurysm	0.00954	0.0114	CbGpPWpGaD
Sulfasalazine—ACAT1—cerebellum—intracranial aneurysm	0.00938	0.0583	CbGeAlD
Sulfasalazine—IKBKB—AGE/RAGE pathway—NCF1—intracranial aneurysm	0.00865	0.0103	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00822	0.0098	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—SLC25A16—intracranial aneurysm	0.00791	0.00942	CbGpPWpGaD
Sulfasalazine—CHUK—Osteopontin-mediated events—MMP2—intracranial aneurysm	0.00773	0.00922	CbGpPWpGaD
Sulfasalazine—ACAT1—brain—intracranial aneurysm	0.00762	0.0473	CbGeAlD
Sulfasalazine—TBXAS1—Metabolism—SLC25A16—intracranial aneurysm	0.00757	0.00903	CbGpPWpGaD
Sulfasalazine—PTGS1—artery—intracranial aneurysm	0.00752	0.0468	CbGeAlD
Sulfasalazine—SLC7A11—midbrain—intracranial aneurysm	0.00744	0.0462	CbGeAlD
Sulfasalazine—PTGS2—artery—intracranial aneurysm	0.00719	0.0447	CbGeAlD
Sulfasalazine—SLC7A11—NRF2 pathway—AGER—intracranial aneurysm	0.00704	0.00838	CbGpPWpGaD
Sulfasalazine—SLC46A1—cerebellum—intracranial aneurysm	0.00699	0.0434	CbGeAlD
Sulfasalazine—CHUK—cerebellum—intracranial aneurysm	0.00699	0.0434	CbGeAlD
Sulfasalazine—CHUK—Toll-Like Receptors Cascades—CTSS—intracranial aneurysm	0.00686	0.00818	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism—ASAH1—intracranial aneurysm	0.00662	0.00789	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—SLC25A16—intracranial aneurysm	0.00662	0.00789	CbGpPWpGaD
Sulfasalazine—IKBKB—GMCSF-mediated signaling events—CCL2—intracranial aneurysm	0.0064	0.00763	CbGpPWpGaD
Sulfasalazine—CHUK—TWEAK Signaling Pathway—CCL2—intracranial aneurysm	0.00638	0.0076	CbGpPWpGaD
Sulfasalazine—TBXAS1—brain—intracranial aneurysm	0.00637	0.0396	CbGeAlD
Sulfasalazine—CHUK—Toll-Like Receptors Cascades—CTSK—intracranial aneurysm	0.00631	0.00752	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll-Like Receptors Cascades—CTSS—intracranial aneurysm	0.00622	0.00741	CbGpPWpGaD
Sulfasalazine—CHUK—Cytosolic sensors of pathogen-associated DNA—AGER—intracranial aneurysm	0.00619	0.00738	CbGpPWpGaD
Sulfasalazine—CHUK—AGE/RAGE pathway—AGER—intracranial aneurysm	0.00619	0.00738	CbGpPWpGaD
Sulfasalazine—ALOX5—Selenium Micronutrient Network—CCL2—intracranial aneurysm	0.00607	0.00724	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00583	0.00694	CbGpPWpGaD
Sulfasalazine—CHUK—Osteopontin-mediated events—MMP9—intracranial aneurysm	0.00581	0.00693	CbGpPWpGaD
Sulfasalazine—IKBKB—TWEAK Signaling Pathway—CCL2—intracranial aneurysm	0.00578	0.00689	CbGpPWpGaD
Sulfasalazine—SLC7A11—cerebellum—intracranial aneurysm	0.00575	0.0358	CbGeAlD
Sulfasalazine—IKBKB—Toll-Like Receptors Cascades—CTSK—intracranial aneurysm	0.00573	0.00682	CbGpPWpGaD
Sulfasalazine—CHUK—brain—intracranial aneurysm	0.00567	0.0353	CbGeAlD
Sulfasalazine—SLC46A1—brain—intracranial aneurysm	0.00567	0.0353	CbGeAlD
Sulfasalazine—IKBKB—AGE/RAGE pathway—AGER—intracranial aneurysm	0.00562	0.00669	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytosolic sensors of pathogen-associated DNA—AGER—intracranial aneurysm	0.00562	0.00669	CbGpPWpGaD
Sulfasalazine—CHUK—TRAF6 Mediated Induction of proinflammatory cytokines—AGER—intracranial aneurysm	0.00559	0.00666	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—SLC25A16—intracranial aneurysm	0.00553	0.00659	CbGpPWpGaD
Sulfasalazine—PLA2G1B—brain—intracranial aneurysm	0.00534	0.0332	CbGeAlD
Sulfasalazine—CHUK—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—AGER—intracranial aneurysm	0.00531	0.00633	CbGpPWpGaD
Sulfasalazine—CHUK—Toll-Like Receptors Cascades—CTSB—intracranial aneurysm	0.00523	0.00623	CbGpPWpGaD
Sulfasalazine—CHUK—IL-1 signaling pathway—CCL2—intracranial aneurysm	0.00514	0.00612	CbGpPWpGaD
Sulfasalazine—CHUK—BDNF signaling pathway—NCF1—intracranial aneurysm	0.00511	0.00609	CbGpPWpGaD
Sulfasalazine—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—AGER—intracranial aneurysm	0.00507	0.00604	CbGpPWpGaD
Sulfasalazine—CHUK—MyD88 cascade initiated on plasma membrane—AGER—intracranial aneurysm	0.00506	0.00603	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—ASAH1—intracranial aneurysm	0.00502	0.00598	CbGpPWpGaD
Sulfasalazine—CHUK—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—AGER—intracranial aneurysm	0.00501	0.00597	CbGpPWpGaD
Sulfasalazine—CHUK—MyD88 dependent cascade initiated on endosome—AGER—intracranial aneurysm	0.00492	0.00586	CbGpPWpGaD
Sulfasalazine—IKBKB—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—AGER—intracranial aneurysm	0.00481	0.00574	CbGpPWpGaD
Sulfasalazine—PPARG—Circadian rythm related genes—CST3—intracranial aneurysm	0.0048	0.00572	CbGpPWpGaD
Sulfasalazine—IKBKB—cerebellum—intracranial aneurysm	0.00475	0.0295	CbGeAlD
Sulfasalazine—CHUK—Toll Like Receptor 9 (TLR9) Cascade—AGER—intracranial aneurysm	0.00475	0.00566	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll-Like Receptors Cascades—CTSB—intracranial aneurysm	0.00474	0.00565	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.00469	0.00559	CbGpPWpGaD
Sulfasalazine—SLC7A11—brain—intracranial aneurysm	0.00467	0.029	CbGeAlD
Sulfasalazine—CHUK—MyD88:Mal cascade initiated on plasma membrane—AGER—intracranial aneurysm	0.00467	0.00556	CbGpPWpGaD
Sulfasalazine—IKBKB—IL-1 signaling pathway—CCL2—intracranial aneurysm	0.00466	0.00555	CbGpPWpGaD
Sulfasalazine—IKBKB—BDNF signaling pathway—NCF1—intracranial aneurysm	0.00464	0.00553	CbGpPWpGaD
Sulfasalazine—IKBKB—MyD88 cascade initiated on plasma membrane—AGER—intracranial aneurysm	0.00459	0.00547	CbGpPWpGaD
Sulfasalazine—CHUK—TWEAK Signaling Pathway—MMP9—intracranial aneurysm	0.00456	0.00543	CbGpPWpGaD
Sulfasalazine—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—AGER—intracranial aneurysm	0.00454	0.00541	CbGpPWpGaD
Sulfasalazine—CHUK—MyD88-independent cascade—AGER—intracranial aneurysm	0.00448	0.00534	CbGpPWpGaD
Sulfasalazine—IKBKB—MyD88 dependent cascade initiated on endosome—AGER—intracranial aneurysm	0.00446	0.00532	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—ASAH1—intracranial aneurysm	0.00439	0.00523	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—AGER—intracranial aneurysm	0.00431	0.00513	CbGpPWpGaD
Sulfasalazine—IKBKB—MyD88:Mal cascade initiated on plasma membrane—AGER—intracranial aneurysm	0.00423	0.00504	CbGpPWpGaD
Sulfasalazine—CHUK—AGE/RAGE pathway—MMP2—intracranial aneurysm	0.00423	0.00504	CbGpPWpGaD
Sulfasalazine—IKBKB—TWEAK Signaling Pathway—MMP9—intracranial aneurysm	0.00413	0.00493	CbGpPWpGaD
Sulfasalazine—IKBKB—MyD88-independent cascade—AGER—intracranial aneurysm	0.00406	0.00484	CbGpPWpGaD
Sulfasalazine—CHUK—Activated TLR4 signalling—AGER—intracranial aneurysm	0.00403	0.0048	CbGpPWpGaD
Sulfasalazine—CHUK—AGE/RAGE pathway—NOS3—intracranial aneurysm	0.00396	0.00472	CbGpPWpGaD
Sulfasalazine—ALOX5—cerebellum—intracranial aneurysm	0.00394	0.0245	CbGeAlD
Sulfasalazine—ALOX5—Metabolism—SLC25A16—intracranial aneurysm	0.00392	0.00467	CbGpPWpGaD
Sulfasalazine—IKBKB—brain—intracranial aneurysm	0.00386	0.024	CbGeAlD
Sulfasalazine—IKBKB—AGE/RAGE pathway—MMP2—intracranial aneurysm	0.00383	0.00457	CbGpPWpGaD
Sulfasalazine—CHUK—Toll Like Receptor 4 (TLR4) Cascade—AGER—intracranial aneurysm	0.00379	0.00451	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—TIMP1—intracranial aneurysm	0.00369	0.0044	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—ASAH1—intracranial aneurysm	0.00366	0.00436	CbGpPWpGaD
Sulfasalazine—IKBKB—Activated TLR4 signalling—AGER—intracranial aneurysm	0.00365	0.00435	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00361	0.0043	CbGpPWpGaD
Sulfasalazine—IKBKB—AGE/RAGE pathway—NOS3—intracranial aneurysm	0.00359	0.00428	CbGpPWpGaD
Sulfasalazine—CHUK—Leptin signaling pathway—NOS3—intracranial aneurysm	0.00357	0.00426	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—AGER—intracranial aneurysm	0.00343	0.00409	CbGpPWpGaD
Sulfasalazine—CHUK—TNF alpha Signaling Pathway—CCL2—intracranial aneurysm	0.00341	0.00406	CbGpPWpGaD
Sulfasalazine—CHUK—Toll-Like Receptors Cascades—AGER—intracranial aneurysm	0.00337	0.00402	CbGpPWpGaD
Sulfasalazine—IKBKB—Leptin signaling pathway—NOS3—intracranial aneurysm	0.00324	0.00386	CbGpPWpGaD
Sulfasalazine—ALOX5—brain—intracranial aneurysm	0.0032	0.0199	CbGeAlD
Sulfasalazine—CHUK—AGE/RAGE pathway—MMP9—intracranial aneurysm	0.00318	0.00378	CbGpPWpGaD
Sulfasalazine—IKBKB—TNF alpha Signaling Pathway—CCL2—intracranial aneurysm	0.00309	0.00368	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll-Like Receptors Cascades—AGER—intracranial aneurysm	0.00306	0.00365	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—CST3—intracranial aneurysm	0.00303	0.00361	CbGpPWpGaD
Sulfasalazine—ABCC2—NRF2 pathway—AGER—intracranial aneurysm	0.00293	0.00349	CbGpPWpGaD
Sulfasalazine—IKBKB—AGE/RAGE pathway—MMP9—intracranial aneurysm	0.00288	0.00343	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00284	0.00338	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.00278	0.00331	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—STARD13—intracranial aneurysm	0.00275	0.00327	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—SLC25A16—intracranial aneurysm	0.00272	0.00324	CbGpPWpGaD
Sulfasalazine—ABCG2—medulla oblongata—intracranial aneurysm	0.00268	0.0167	CbGeAlD
Sulfasalazine—SLC46A1—Disease—NCF1—intracranial aneurysm	0.00263	0.00314	CbGpPWpGaD
Sulfasalazine—PTGS1—Selenium Micronutrient Network—CCL2—intracranial aneurysm	0.00263	0.00314	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—ASAH1—intracranial aneurysm	0.00259	0.00309	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00253	0.00301	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—STARD13—intracranial aneurysm	0.00249	0.00297	CbGpPWpGaD
Sulfasalazine—ABCG2—midbrain—intracranial aneurysm	0.00245	0.0152	CbGeAlD
Sulfasalazine—PPARG—Metabolism—SLC25A16—intracranial aneurysm	0.00242	0.00289	CbGpPWpGaD
Sulfasalazine—PPARG—brain—intracranial aneurysm	0.0024	0.0149	CbGeAlD
Sulfasalazine—CHUK—Innate Immune System—CTSS—intracranial aneurysm	0.00222	0.00265	CbGpPWpGaD
Sulfasalazine—PTGS2—medulla oblongata—intracranial aneurysm	0.00214	0.0133	CbGeAlD
Sulfasalazine—CHUK—Adaptive Immune System—CTSS—intracranial aneurysm	0.00213	0.00254	CbGpPWpGaD
Sulfasalazine—PTGS2—Selenium Micronutrient Network—CCL2—intracranial aneurysm	0.00209	0.00249	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—CTSK—intracranial aneurysm	0.00205	0.00244	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—CTSS—intracranial aneurysm	0.00202	0.0024	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00201	0.00239	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CTSK—intracranial aneurysm	0.00196	0.00234	CbGpPWpGaD
Sulfasalazine—PTGS2—midbrain—intracranial aneurysm	0.00195	0.0121	CbGeAlD
Sulfasalazine—IKBKB—Adaptive Immune System—CTSS—intracranial aneurysm	0.00194	0.00231	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—SLC25A16—intracranial aneurysm	0.00191	0.00228	CbGpPWpGaD
Sulfasalazine—ABCG2—cerebellum—intracranial aneurysm	0.00189	0.0118	CbGeAlD
Sulfasalazine—IKBKB—Innate Immune System—CTSK—intracranial aneurysm	0.00185	0.00221	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CTSK—intracranial aneurysm	0.00178	0.00212	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—SLC25A16—intracranial aneurysm	0.00177	0.00211	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by SCF-KIT—MMP9—intracranial aneurysm	0.00173	0.00206	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—SLC25A16—intracranial aneurysm	0.0017	0.00202	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—CTSB—intracranial aneurysm	0.00169	0.00202	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—NOS3—intracranial aneurysm	0.00166	0.00198	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—CCL2—intracranial aneurysm	0.00165	0.00197	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CTSB—intracranial aneurysm	0.00163	0.00194	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—NCF1—intracranial aneurysm	0.00162	0.00193	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—SLC25A16—intracranial aneurysm	0.00161	0.00192	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—ASAH1—intracranial aneurysm	0.00161	0.00191	CbGpPWpGaD
Sulfasalazine—ABCG2—brain—intracranial aneurysm	0.00154	0.00956	CbGeAlD
Sulfasalazine—IKBKB—Innate Immune System—CTSB—intracranial aneurysm	0.00154	0.00183	CbGpPWpGaD
Sulfasalazine—PTGS2—cerebellum—intracranial aneurysm	0.00151	0.00939	CbGeAlD
Sulfasalazine—IKBKB—Adaptive Immune System—CTSB—intracranial aneurysm	0.00147	0.00176	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—NCF1—intracranial aneurysm	0.00147	0.00175	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism—NOS3—intracranial aneurysm	0.00138	0.00165	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—SLC25A16—intracranial aneurysm	0.00135	0.00161	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CTSS—intracranial aneurysm	0.00129	0.00154	CbGpPWpGaD
Sulfasalazine—PTGS1—brain—intracranial aneurysm	0.00128	0.00798	CbGeAlD
Sulfasalazine—CYP3A5—Metabolism—SLC25A16—intracranial aneurysm	0.00127	0.00151	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—ASAH1—intracranial aneurysm	0.00126	0.00151	CbGpPWpGaD
Sulfasalazine—PTGS2—brain—intracranial aneurysm	0.00123	0.00762	CbGeAlD
Sulfasalazine—CHUK—Immune System—CTSK—intracranial aneurysm	0.00119	0.00142	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—MMP9—intracranial aneurysm	0.00118	0.00141	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CTSS—intracranial aneurysm	0.00117	0.0014	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—ASAH1—intracranial aneurysm	0.00117	0.0014	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—ASAH1—intracranial aneurysm	0.00113	0.00134	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—AGER—intracranial aneurysm	0.00109	0.0013	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—NOS3—intracranial aneurysm	0.00109	0.0013	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CTSK—intracranial aneurysm	0.00108	0.00129	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—NOS3—intracranial aneurysm	0.00105	0.00125	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CST3—intracranial aneurysm	0.00104	0.00124	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—AGER—intracranial aneurysm	0.000991	0.00118	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CTSB—intracranial aneurysm	0.000986	0.00118	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—NCF1—intracranial aneurysm	0.000981	0.00117	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—NOS3—intracranial aneurysm	0.000915	0.00109	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—NCF1—intracranial aneurysm	0.000906	0.00108	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—MMP2—intracranial aneurysm	0.000899	0.00107	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CTSB—intracranial aneurysm	0.000894	0.00107	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ASAH1—intracranial aneurysm	0.000893	0.00106	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—NCF1—intracranial aneurysm	0.00089	0.00106	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ASAH1—intracranial aneurysm	0.000839	0.001	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—NOS3—intracranial aneurysm	0.000764	0.00091	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—MMP9—intracranial aneurysm	0.000676	0.000806	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—AGER—intracranial aneurysm	0.000637	0.000759	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—NCF1—intracranial aneurysm	0.000634	0.000756	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CST3—intracranial aneurysm	0.000617	0.000735	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—EDNRA—intracranial aneurysm	0.000599	0.000714	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—AGER—intracranial aneurysm	0.000577	0.000688	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NCF1—intracranial aneurysm	0.000575	0.000685	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—EDNRA—intracranial aneurysm	0.000543	0.000647	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—NOS3—intracranial aneurysm	0.000541	0.000645	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NCF1—intracranial aneurysm	0.000537	0.000639	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—NOS3—intracranial aneurysm	0.000376	0.000448	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—NOS3—intracranial aneurysm	0.000335	0.000399	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCL2—intracranial aneurysm	0.000295	0.000352	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCL2—intracranial aneurysm	0.000268	0.000319	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—NOS3—intracranial aneurysm	0.000264	0.000314	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—NOS3—intracranial aneurysm	0.000263	0.000314	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—NOS3—intracranial aneurysm	0.000244	0.000291	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NOS3—intracranial aneurysm	0.000239	0.000284	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—NOS3—intracranial aneurysm	0.000235	0.00028	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NOS3—intracranial aneurysm	0.000223	0.000265	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MMP9—intracranial aneurysm	0.000211	0.000252	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MMP9—intracranial aneurysm	0.000191	0.000228	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—NOS3—intracranial aneurysm	0.000186	0.000222	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—NOS3—intracranial aneurysm	0.000175	0.000209	CbGpPWpGaD
